戻る Agenda
Strategic Partnerships: Emerging Models and Their Impact on Drug Development
Session Chair(s)
Neil Ferguson
Chief Business Officer
Syneos Health , United States
Strategic partnerships are gaining significant traction in the Sponsor-CRO relationship. This forum brings together experts to discuss both macro trends and individual companies’ approaches to success.
Learning Objective : Explain the evolution of strategic partnership models between CROs and sponsors; Discuss emerging models and how they are impacting both drug development and the internal operations of CROs; Describe the future of sponsor-CRO partner relations and how they will impact the industry.
Speaker(s)
Panelist
David D Lilley
SFJ Pharmaceuticals Inc., United States
Non Executive Board Director
Panelist
Mitchell A. Katz, PHD
Ferring Pharmaceuticals, United States
Vice President, Development Operations
Panelist
Kent Allenby, MD, FACP
1963, United States
1963